When markets turn choppy, these stocks will be the first...
When hedge funds race for the door, don't get left holding the bag. This...read more
Jupiter Diagnostics Ltd previously known as L3T is addressing the $10bn global market for cholesterol testing, using technology from a leading team of scientists based at STFC’s Daresbury Laboratory in Cheshire to develop a diagnostic tool for full spectrum cholesterol testing at the point of care.
A 2004 RSF pathfinder funded some confirmatory research to back up claims in a patent, with further investment since taking the total to £242,000. The company has recently raised a further £1.7m from angels and venture funds and expects to have a fully functioning device within the next six to twelve months.
Associated Fund UK Innovation & Science Seed Fund
Sector Medical / Biotechnology